Haikou Affiliated Hospital Of Central South University Xiangya School Of Medicine
Clinical trials sponsored by Haikou Affiliated Hospital Of Central South University Xiangya School Of Medicine, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a safer dose of an old drug shield vulnerable children from deadly fungal infections? Results expected Feb 2027 (estimated)
-
A drug that may speed platelet recovery after stem cell transplants in kids
Disease control CompletedThis study explores whether romiplostim, a drug that stimulates platelet production, can safely and effectively help platelet recovery in children with thalassemia who receive a half-matched stem cell transplant. Researchers will track how quickly platelet levels rise, how many p…
Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
A drug that boosts platelets may speed recovery after stem cell transplants in kids with thalassemia
Disease control CompletedThis observational study tests whether hetrombopag, a platelet-boosting drug, can safely speed platelet recovery in children with thalassemia who receive a half-matched (haploidentical) stem cell transplant. Thirty children aged 2 to 17 will be followed for 28 days after transpla…
Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC